Accession Number ADA564586
Title Role of Mitochondrial TCA Cycle Enzymes in Determining Prostate Cancer Chemosensitivity.
Publication Date Mar 2012
Media Count 8p
Personal Author D. Qian
Abstract Based on the results in preliminary data and in year No. 1 of the proposal, we hypothesize that MDH2 plays a crucial role in determining prostate cancer chemosensitivity. In year No. 2, we further determined the effect of inhibiting MDH2 on prostate cancer energy metabolism and response to chemotherapy. We found that MDH2 knockdown via stable shRNA significantly disrupts the metabolic efficiency and redox balance in prostate cancer cells. Further, we made a novel observation that MDH2 knockdown significantly enhances the chemotherapy induced signaling cascade that is required to exert mitochondria-based apoptosis. This provides a potential mechanism underpinning the observed clinical correlation between MDH2 and outcome of chemotherapy in prostate cancer. It also presents evidence for the first time that MDH2 can be a novel molecular target to improve prostate cancer chemotherapy.
Keywords Chemosensitivity
Chemotherapy
Clinical medicine
Docetaxel
Enzymes
Metabolism
Mitochondria
Molecules
Prostate cancer
Prostate gland


 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author Oregon Health and Sciences Univ., Portland.
Document Type Technical report
Title Note Annual rept. 1 Mar 2010-29 Feb 2012.
NTIS Issue Number 1303
Contract Number W81XWH-10-1-0142

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader